Summit Therapeutics is Biotechnology in United Kingdom that focus on Summit Therapeutics Inc business. Founded in 2003. They cover business area such as Summit Therapeutics Inc, development, commercialization, novel antibiotic, serious infectious disease, its lead CDI, (Clostridiodes difficile infection) product candidate, ridinilazole, three geographical segment, United States, Latin America, Europe.
2003
( 21 years old in 2024 )
Summit Therapeutics Inc
-
136a Eastern Avenue
Milton Park
Abingdon OX14 4SB
England, United Kingdom
Private
Summit Therapeutics Incdevelopmentcommercializationnovel antibioticserious infectious diseaseits lead CDI(Clostridiodes difficile infection) product candidateridinilazolethree geographical segmentUnited StatesLatin AmericaEurope
* We use standard office opening hours in near Summit Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Summit Therapeutics is Biotechnology business from United Kingdom that founded in 2003 (21 years old in 2024), Summit Therapeutics business is focusing on Summit Therapeutics Inc.
Summit Therapeutics headquarter office and corporate office address is located in 136a Eastern Avenue Milton Park Abingdon OX14 4SB England, United Kingdom.
Summit Therapeutics was founded in United Kingdom.
In 2024, Summit Therapeutics is currently focus on Summit Therapeutics Inc sector.
Above is snippet of Google Trends for "Summit Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Summit Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.